Latest Buy Backs News

European Lithium (ASX: EUR) has affirmed its compliance with ASX continuous disclosure rules following its announcement of a non-binding merger proposal with Critical Metals Corp. (CRML). The company detailed its negotiation timeline and rationale for the timing of its market disclosures.

Fat Prophets Global Contrarian Fund (ASX: FPC) has kicked off a non-renounceable rights issue aiming to raise up to $8.45 million, with directors and a $1 million underwriter backing the offer. The capital raise is designed to boost liquidity, grow assets, and enhance market presence.

Sports Entertainment Group (SEG) has upgraded its FY26 Underlying EBITDA guidance to a range of $15.5 million to $16.5 million, reflecting broad-based growth and operational efficiencies across its media and events businesses.

Fat Prophets Global Contrarian Fund (ASX: FPC) has launched an on-market buy-back of its ordinary shares, set to run from May 2026 to May 2027, signalling a fresh phase in its capital management strategy.

ANZ Group Holdings Limited posted a 14% rise in cash profit for 1H26 to AUD 3.78 billion, driven by cost reductions and steady revenue, while declaring an 83-cent interim dividend with 75% franking.

Zenith Minerals has reported a significant milestone with a maiden 675,000-ounce JORC Inferred Mineral Resource at its Consolidated Dulcie Gold Project, alongside deep drilling success at Red Mountain that extends mineralisation beyond 700 metres.

ACDC Metals (ASX: ADC) has acquired an option to earn full ownership of the Mount Jackson gold-silver project in Nevada’s prolific Walker Lane district, backed by a $0.935 million placement and a planned $1.56 million rights issue to fund exploration.

hipages Group (ASX:HPG) has kicked off an on-market buy-back of up to 10% of its shares, signalling confidence in its undervalued stock amid strong cash flow and growth.

MPR Australia has no ongoing operations following its $19 million asset sale and is weighing shareholder returns against new business acquisitions amid legacy claims.

Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.

Central Petroleum lifted March quarter sales revenue to $11.3 million, driven by higher gas volumes and prices, while securing a significant multi-year gas supply deal with the Northern Territory Government that supports a 40% production capacity increase at Palm Valley.

Whitehaven Coal’s March quarter production fell 14% due to seasonal wet weather in Queensland, but coal prices rose sharply and refinancing cut interest costs by up to A$55 million annually.